![](/img/cover-not-exists.png)
MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure
Agrawal, M, Hanfstein, B, Erben, P, Wolf, D, Ernst, T, Fabarius, A, Saussele, S, Purkayastha, D, Woodman, R C, Hofmann, W-K, Hehlmann, R, Hochhaus, A, Müller, M CVolume:
28
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2014.6
Date:
July, 2014
File:
PDF, 831 KB
english, 2014